• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸道合胞病毒(RSV)-A 感染造血细胞移植受者的抗原指纹图谱揭示了黏膜抗 RSV G 抗体在控制人类 RSV 感染中的重要性。

Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans.

机构信息

Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.

University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

出版信息

J Infect Dis. 2020 Feb 3;221(4):636-646. doi: 10.1093/infdis/jiz608.

DOI:10.1093/infdis/jiz608
PMID:31745552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7530544/
Abstract

BACKGROUND

Respiratory syncytial virus (RSV) infection causes significant morbidity in hematopoietic cell transplant (HCT) recipients. However, antibody responses that correlate with recovery from RSV disease are not fully understood.

METHODS

In this study, antibody repertoire in paired serum and nasal wash samples from acutely RSV-A-infected HCT recipients who recovered early (<14 days of RSV shedding) were compared with late-recovered patients (≥14 days of shedding) using gene fragment phage display libraries and surface plasmon resonance.

RESULTS

Anti-F serum responses were similar between these 2 groups for antibody repertoires, neutralization titers, anti-F binding antibodies (prefusion and postfusion proteins), antibody avidity, and binding to specific antigenic sites. In contrast, nasal washes from early-recovered individuals demonstrated higher binding to F peptide containing p27. While the serum RSV G antibody repertoires in the 2 groups were similar, the strongest difference between early-recovered and late-recovered patients was observed in the titers of nasal wash antibodies, especially binding to the central conserved domain. Most importantly, a significantly higher antibody affinity to RSV G was observed in nasal washes from early-recovered individuals compared with late-recovered HCT recipients.

CONCLUSIONS

These findings highlight the importance of mucosal antibodies in resolution of RSV-A infection in the upper respiratory tract.

摘要

背景

呼吸道合胞病毒(RSV)感染会导致造血细胞移植(HCT)受者出现严重的发病率。然而,与 RSV 疾病恢复相关的抗体反应尚未完全了解。

方法

在这项研究中,我们比较了急性 RSV-A 感染并早期(<14 天 RSV 脱落)恢复的 HCT 受者与晚期恢复(≥14 天脱落)患者配对的血清和鼻冲洗样本中的抗体库,使用基因片段噬菌体展示文库和表面等离子体共振技术。

结果

对于抗体库、中和滴度、抗 F 结合抗体(融合前和融合后蛋白)、抗体亲合力和与特定抗原表位的结合,这两组的抗 F 血清反应相似。相比之下,早期恢复患者的鼻冲洗液对包含 p27 的 F 肽的结合更高。虽然两组血清 RSV G 抗体库相似,但早期恢复和晚期恢复患者之间最强的差异是鼻冲洗抗体的滴度,尤其是对中央保守域的结合。最重要的是,与晚期恢复的 HCT 受者相比,早期恢复患者的鼻冲洗液中对 RSV G 的抗体亲和力明显更高。

结论

这些发现强调了黏膜抗体在解决上呼吸道 RSV-A 感染中的重要性。

相似文献

1
Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans.呼吸道合胞病毒(RSV)-A 感染造血细胞移植受者的抗原指纹图谱揭示了黏膜抗 RSV G 抗体在控制人类 RSV 感染中的重要性。
J Infect Dis. 2020 Feb 3;221(4):636-646. doi: 10.1093/infdis/jiz608.
2
Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients.呼吸道合胞病毒(RSV)感染的成人造血细胞移植(HCT)受者对 RSV 结构蛋白的体液和黏膜抗体反应。
Viruses. 2021 May 26;13(6):991. doi: 10.3390/v13060991.
3
Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins.幼儿初次感染呼吸道合胞病毒后的抗原指纹分析确定了新的抗原位点,并揭示了人类抗体库对融合糖蛋白和附着糖蛋白的非关联进化。
PLoS Pathog. 2016 Apr 21;12(4):e1005554. doi: 10.1371/journal.ppat.1005554. eCollection 2016 Apr.
4
Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients.比较帕利珠单抗类似抗体与 RSV 感染的成人造血细胞移植受者中不同构象的 RSV F 蛋白的结合。
J Infect Dis. 2018 Mar 28;217(8):1247-1256. doi: 10.1093/infdis/jiy026.
5
Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.自然感染及用福尔马林灭活呼吸道合胞病毒(RSV)疫苗接种后表位特异性抗呼吸道合胞病毒(抗RSV)抗体反应的特征分析
J Virol. 2016 Jun 10;90(13):5965-5977. doi: 10.1128/JVI.00235-16. Print 2016 Jul 1.
6
Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults.针对呼吸道合胞病毒融合蛋白的抗原表位特异性竞争抗体反应与造血细胞移植成人的病毒清除有关。
Front Immunol. 2019 Mar 29;10:706. doi: 10.3389/fimmu.2019.00706. eCollection 2019.
7
Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (p27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Adult Hematopoietic Cell Transplant (HCT) Recipients.呼吸道合胞病毒(RSV)感染的成人造血细胞移植(HCT)受者对融合蛋白中弗林蛋白酶可切割的27个氨基酸肽(p27)的抗体反应。
Vaccines (Basel). 2020 Apr 21;8(2):192. doi: 10.3390/vaccines8020192.
8
Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection.呼吸道合胞病毒预融合(F)蛋白纳米颗粒疫苗:结构、抗原谱、免疫原性和保护作用。
Vaccine. 2019 Sep 24;37(41):6112-6124. doi: 10.1016/j.vaccine.2019.07.089. Epub 2019 Aug 12.
9
Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains.呼吸道合胞病毒 G 附着蛋白中非中央保守和半胱氨酸环区域的保护性抗原表位。
PLoS Pathog. 2018 Aug 24;14(8):e1007262. doi: 10.1371/journal.ppat.1007262. eCollection 2018 Aug.
10
Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein.人呼吸道合胞病毒(RSV) G 蛋白 CX3C 基序和分泌形式改变对表达 RSV G 蛋白的副流感病毒载体免疫反应的影响。
J Virol. 2019 Mar 21;93(7). doi: 10.1128/JVI.02043-18. Print 2019 Apr 1.

引用本文的文献

1
A multi-center study on genetic variations in the fusion protein of respiratory syncytial virus from children with Acute Lower Respiratory Tract Infections in China during 2017-2021.一项关于 2017-2021 年期间中国急性下呼吸道感染儿童呼吸道合胞病毒融合蛋白基因变异的多中心研究。
Virol Sin. 2024 Oct;39(5):727-736. doi: 10.1016/j.virs.2024.09.002. Epub 2024 Sep 13.
2
Monoclonal antibodies targeting sites in respiratory syncytial virus attachment G protein provide protection against RSV-A and RSV-B in mice.针对呼吸道合胞病毒附着 G 蛋白中位点的单克隆抗体为小鼠提供了针对 RSV-A 和 RSV-B 的保护。
Nat Commun. 2024 Apr 4;15(1):2900. doi: 10.1038/s41467-024-47146-2.
3
All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design?所有目光都聚焦在预融合稳定的F结构上,但我们是否忽略了呼吸道合胞病毒疫苗设计中替代靶点的潜力?
Vaccines (Basel). 2024 Jan 18;12(1):97. doi: 10.3390/vaccines12010097.
4
The RSV F p27 peptide: current knowledge, important questions.呼吸道合胞病毒融合蛋白p27肽:当前认知与重要问题
Front Microbiol. 2023 Jun 21;14:1219846. doi: 10.3389/fmicb.2023.1219846. eCollection 2023.
5
Immunization with a mucosal, post-fusion F/G protein-based polyanhydride nanovaccine protects neonatal calves against BRSV infection.黏膜型融合后 F/G 蛋白多聚酸酐纳米疫苗免疫可保护新生犊牛免受 BRSV 感染。
Front Immunol. 2023 Jun 9;14:1186184. doi: 10.3389/fimmu.2023.1186184. eCollection 2023.
6
A tool for evaluating heterogeneity in avidity of polyclonal antibodies.一种评估多克隆抗体亲合力异质性的工具。
Front Immunol. 2023 Feb 16;14:1049673. doi: 10.3389/fimmu.2023.1049673. eCollection 2023.
7
The Quest for a Respiratory Syncytial Virus Vaccine for Older Adults: Thinking beyond the F Protein.为老年人研发呼吸道合胞病毒疫苗的探索:超越融合蛋白的思考
Vaccines (Basel). 2023 Feb 7;11(2):382. doi: 10.3390/vaccines11020382.
8
Antibody responses of healthy adults to the p27 peptide of respiratory syncytial virus fusion protein.健康成年人对呼吸道合胞病毒融合蛋白 p27 肽的抗体反应。
Vaccine. 2022 Jan 24;40(3):536-543. doi: 10.1016/j.vaccine.2021.11.087. Epub 2021 Dec 10.
9
Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2-infected individuals reveal unlinked immune signatures.无症状和有症状的新冠病毒感染者的全身和黏膜免疫分析揭示了不相关的免疫特征。
Sci Adv. 2021 Oct 15;7(42):eabi6533. doi: 10.1126/sciadv.abi6533. Epub 2021 Oct 13.
10
Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern.严重急性呼吸综合征冠状病毒2型高效价静脉注射用人免疫球蛋白的表位多样性及对关注变异株的中和作用
iScience. 2021 Sep 24;24(9):103006. doi: 10.1016/j.isci.2021.103006. Epub 2021 Aug 20.

本文引用的文献

1
Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans.重复接种会降低人类不同流感疫苗平台的抗体亲和力成熟。
Nat Commun. 2019 Jul 26;10(1):3338. doi: 10.1038/s41467-019-11296-5.
2
Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome.寨卡病毒感染后人类抗体库的差异及其对血清学诊断和疾病结局的影响。
Nat Commun. 2019 Apr 26;10(1):1943. doi: 10.1038/s41467-019-09914-3.
3
Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults.针对呼吸道合胞病毒融合蛋白的抗原表位特异性竞争抗体反应与造血细胞移植成人的病毒清除有关。
Front Immunol. 2019 Mar 29;10:706. doi: 10.3389/fimmu.2019.00706. eCollection 2019.
4
Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains.呼吸道合胞病毒 G 附着蛋白中非中央保守和半胱氨酸环区域的保护性抗原表位。
PLoS Pathog. 2018 Aug 24;14(8):e1007262. doi: 10.1371/journal.ppat.1007262. eCollection 2018 Aug.
5
A multifaceted approach to RSV vaccination.RSV 疫苗接种的多方面方法。
Hum Vaccin Immunother. 2018 Jul 3;14(7):1734-1745. doi: 10.1080/21645515.2018.1472183. Epub 2018 Jun 19.
6
Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients.比较帕利珠单抗类似抗体与 RSV 感染的成人造血细胞移植受者中不同构象的 RSV F 蛋白的结合。
J Infect Dis. 2018 Mar 28;217(8):1247-1256. doi: 10.1093/infdis/jiy026.
7
Passive and active immunization against respiratory syncytial virus for the young and old.针对年轻人和老年人的呼吸道合胞病毒被动免疫和主动免疫。
Expert Rev Vaccines. 2017 Jul;16(7):1-13. doi: 10.1080/14760584.2017.1333425. Epub 2017 Jun 7.
8
Vaccine development for respiratory syncytial virus.呼吸道合胞病毒疫苗的研发
Curr Opin Virol. 2017 Apr;23:107-112. doi: 10.1016/j.coviro.2017.03.012. Epub 2017 May 16.
9
Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model.细菌表达的 RSV-G 蛋白疫苗的临床前评价:在棉鼠模型中对 RSV 挑战具有强大的保护作用。
Sci Rep. 2017 Feb 10;7:42428. doi: 10.1038/srep42428.
10
Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.呼吸道合胞病毒(RSV)在病毒感染的活体小鼠中的生物发光成像技术的发展及其在治疗药物和疫苗评估中的应用。
Vaccine. 2017 Jan 23;35(4):694-702. doi: 10.1016/j.vaccine.2016.11.044. Epub 2016 Dec 15.